Alignment Healthcare, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Alignment Healthcare, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Alignment Healthcare, Inc. has recorded 420 insider filings. Market capitalisation: €2.8bn. The latest transaction was filed on 9 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: KAO JOHN E. Every trade is openly available.
Analyst consensus: bullish or bearish? Analysts rate Alignment Healthcare, Inc. Strong Buy (bullish), based on 13 analysts. Average price target: US$24.08.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,710 of 29,064 companies
FCF yld 4.1%
Earn yld -0.0%
EV/EBITDA ·
ROE 20%
Gross mgn 12%
Net mgn -0.0%
Debt/EBITDA 7.3x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
All Executives420 Thresholds0 Prospectus0 Other0
Declarations 420 total
● Chief Executive Officer / Director · Executives · 10 Sept 2026
405,000 shares @ US$13.06 Common Stock SEC144:0001628280-26-061184
● President · Executives · 10 Sept 2026
130,000 shares @ US$13.06 Common Stock SEC144:0001628280-26-061187
▼ President · Executives · 14 Aug 2026
5,000 shares @ US$14.00 0.0025% mcap 0.2% of flow Common Stock SEC:0001628280-26-057635:0
▼ Chief Executive Officer · Executives · 10 Aug 2026
298,000 shares @ US$13.8818 0.14% mcap 3.9% of flow Common Stock SEC:0001628280-26-055418:0
◇ President · Executives · 15 Jul 2026
152,068 shares @ US$9.06 0.050% mcap 3.8% of flow Common Stock SEC:0001628280-26-048498:0
▼ President · Executives · 15 Jul 2026
177,068 shares @ US$20.8281 0.13% mcap 10.1% of flow Common Stock SEC:0001628280-26-048498:1
▼ Chief Executive Officer · Executives · 10 Jul 2026
279,644 shares @ US$19.8122 0.20% mcap 5.4% of flow Common Stock SEC:0001628280-26-048170:0
▼ Chief Executive Officer · Executives · 10 Jul 2026
18,356 shares @ US$20.6471 0.014% mcap 0.4% of flow Common Stock SEC:0001628280-26-048170:1
◆ Chief Operations Officer · Executives · 1 Jul 2026
87,719 shares Common Stock SEC:0001628280-26-046944:0
▼ EVP, Corporate Affairs · Executives · 1 Jul 2026
25,000 shares Common Stock SEC:0001628280-26-046575:0
▼ EVP, Corporate Affairs · Executives · 26 Jun 2026
25,000 shares Common Stock SEC:0001628280-26-045734:0
▼ EVP, Corporate Affairs · Executives · 18 Jun 2026
25,000 shares Common Stock SEC:0001628280-26-044253:0
▼ Chief Medical Officer · Executives · 12 Jun 2026
35,951 shares Common Stock SEC:0001628280-26-043335:0
▼ President · Executives · 15 Jun 2026
30,000 shares Common Stock SEC:0001628280-26-043369:0
● Officer · Executives · 12 Jun 2026
1,142 shares @ US$20.24 0.0008% mcap 100.0% of flow Common SEC144:0001950047-26-006036
▼ Chief Executive Officer · Executives · 10 Jun 2026
74,936 shares Common Stock SEC:0001628280-26-042824:0
▼ Chief Executive Officer · Executives · 10 Jun 2026
223,064 shares Common Stock SEC:0001628280-26-042824:1
▼ EVP, Corporate Affairs · Executives · 11 Jun 2026
25,000 shares Common Stock SEC:0001628280-26-042830:0
◆ EVP, Corporate Affairs · Executives · 3 Jun 2026
122,807 shares 0Common Stock SEC:0001628280-26-041910:0
◆ President - MSO · Executives · 3 Jun 2026
87,719 shares 0Common Stock SEC:0001628280-26-041913:0
▲ President - MSO · Executives · 2 Jun 2026
14,848 shares @ US$13.31 0.0071% mcap 100.0% of flow Common Stock SEC:0001628280-26-040005:0
Canonical exit: 31 Aug 2026 (T+90) ▼ President · Executives · 15 May 2026
30,000 shares @ US$16.0855 0.017% mcap 1.5% of flow Common Stock SEC:0001628280-26-036489:0
● President · Executives · 15 May 2026
1,500 shares 0Common Stock SEC:0001628280-26-036489:1
● President · Executives · 18 May 2026
20,000 shares 0Common Stock SEC:0001628280-26-036489:2
▼ Chief Executive Officer · Executives · 10 Apr 2026
13,801 shares @ US$21.3785 0.011% mcap 0.4% of flow Common Stock SEC:0001628280-26-024978:1
25 of 420 declarations
Load more (395 remaining) 关于 Alignment Healthcare, Inc. Alignment Healthcare, Inc. 是一家总部位于美国的医疗保健服务公司,在纳斯达克上市,股票代码为 ALHC,其运营足迹遍及美国。该公司成立于 2013 年,其既定使命是通过解决美国医疗系统碎片化和复杂性问题,改善老年人的医疗保健服务。其总部位于加利福尼亚州奥兰治,地处洛杉矶地区。([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
该业务的核心是一个下一代、以消费者为中心、以临床为重点的平台,主要为联邦医疗保险受益人,特别是那些参加联邦医疗保险优惠计划的受益人而构建。Alignment Healthcare 将保险、护理协调和临床支持整合到一个综合模型中,旨在简化老年人的医疗保健旅程。管理层强调利用数据和技术来改善医疗服务可及性、弥补护理差距并减少可避免的住院利用率,这是公司价值主张的关键部分。([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
从竞争角度来看,Alignment Healthcare 是一家专业的联邦医疗保险优惠计划参与者,与大型多元化管理式医疗保险公司和其他专注于老年人健康的平台竞争。其差异化在于其紧密整合的护理模式、本地提供商协调和会员体验。在其 2025 年年度报告中,该公司披露截至 2025 年底拥有约 275,300 名健康计划会员,并在 5 个州的 45 个市场开展业务,这突显了强劲的增长,但也表明其地理基础仍然集中。([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
公司的主要产品包括以 Alignment Health Plan 品牌销售的 HMO 和 PPO 联邦医疗保险优惠计划。除了保险包装,产品主张围绕着更便捷的医疗服务、更好的医生协调以及针对居家、数字和社区环境中的老年人量身定制的支持服务。对于投资者而言,主要战略问题仍然是在高度受监管的美国联邦医疗保险环境中,会员增长、医疗成本控制和利润扩张的执行情况。([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
近期发展表明运营势头良好。Alignment Healthcare 在 2026 年初公布了 2025 财年全年业绩,显示会员和收入持续增长,随后在 2026 年 4 月底公布了 2026 年第一季度业绩,管理层称其表现强劲,实现了有纪律的增长和利润扩张。该公司还在近期沟通中更新或上调了 2026 年展望的部分内容,表明对运营轨迹的信心有所增强。作为一家在纳斯达克上市的美国医疗保健公司,也值得关注 SEC Form 4 内部交易,这可以提供有用的背景信息,但不应孤立解读。([globenewswire.com](https://www.globenewswire.com/news-release/2026/02/26/3246044/0/en/alignment-healthcare-reports-fourth-quarter-and-full-year-2025-results-beats-high-end-of-guidance-across-all-key-metrics.html?utm_source=openai))